Pharma-Bio Serv (PBSV) Operating Expenses (2010 - 2026)
Pharma-Bio Serv's (PBSV) quarterly Operating Expenses came in at $757365.0 in Q2 2026, down 17.41% on a YoY basis from $917048.0 in Q2 2025, and down 7.29% quarter-over-quarter from $816909.0 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) Operating Expenses (2010 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported Operating Expenses for 16 consecutive years, with $757365.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses fell 17.41% year-over-year to $757365.0; the trailing twelve-month figure through Apr 2026 stood at $3.3 million (down 9.0% YoY), and the FY2025 full-year result was $3.5 million, down 6.73% from the prior year.
- Operating Expenses eased to $757365.0 in Q2 2026 per PBSV's latest filing, from $816909.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $1.1 million in Q3 2023 and bottomed at $757365.0 in Q2 2026.
- Historically, Operating Expenses has averaged $921172.0 across 5 years, with a median of $924449.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses plunged 85.08% in 2022, then climbed 15.56% in 2023.
- Over 5 years, Operating Expenses stood at $939683.0 in 2022, then climbed by 4.46% to $981570.0 in 2023, then retreated by 10.28% to $880700.0 in 2024, then gained by 0.17% to $882207.0 in 2025, then fell by 14.15% to $757365.0 in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $757365.0, $816909.0, and $882207.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 15.54 Bn |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 267.00 Mn |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | 1.30 Bn |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 5.70 Mn |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 2.52 Bn |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 294.13 Mn |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 666.73 Mn |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | 908.44 Mn |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | 205.89 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 757,365.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 757,365.00 |
| Jan 31, 2026 | 816,909.00 |
| Oct 31, 2025 | 882,207.00 |
| Jul 31, 2025 | 888,139.00 |
| Apr 30, 2025 | 917,048.00 |
| Jan 31, 2025 | 860,300.00 |
| Oct 31, 2024 | 880,700.00 |
| Jul 31, 2024 | 1.02 Mn |
| Apr 30, 2024 | 931,850.00 |
| Jan 31, 2024 | 973,909.00 |
| Oct 31, 2023 | 981,570.00 |
| Jul 31, 2023 | 1.09 Mn |
| Apr 30, 2023 | 966,365.00 |
| Jan 31, 2023 | 911,524.00 |
| Oct 31, 2022 | 939,683.00 |
| Jul 31, 2022 | 942,809.00 |
| Apr 30, 2022 | 935,276.00 |
| Jan 31, 2022 | 888,735.00 |
| Oct 31, 2021 | 6.30 Mn |
| Jul 31, 2021 | 894,572.00 |